Lyndal Hesterberg's Insider Trades & SAST Disclosures

Lyndal Hesterberg's most recent trade in Oncocyte Corporation was a trade of 6,603 Common Stock done . Disclosure was reported to the exchange on Dec. 11, 2020.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Oncocyte Corporation
Lyndal Hesterberg CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2020 6,603 7,477 (0%) 0% - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades